Published in Cancer Weekly, October 14th, 2003
Speaking at ECCO 12 - The European Cancer Conference in Copenhagen, Dr. Xavier Bosch, of the Institut Catala d'Oncologia, Barcelona, Spain, said that testing with a cocktail of the majority of high-risk type virus would provide a sufficient answer for clinical guidance, and be important to the success of any future screening or vaccination programs.
HPV is an extremely common...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.